Co-founder & CEO

Co-Founder & President

0.6666666865348816

Associate Scientist II

Rangam is seeking a highly motivated and skilled Associate Scientist II to contribute to oncology drug discovery efforts. The role involves developing new methods and techniques, conducting experiments, and generating reliable data as part of a multidisciplinary research team.

RCI-ABBV-32176 Associate Scientist (Mammalian Cell Culture/PCR/gDNA Extraction/NGS/Library Preparation)

Executive Vice President & Chief Scientific Officer & Global Head BD&L

Sr. Human Resources Business Partner

Revealed: global funds, from BlackRock to Temasek, back China’s largest biotech firms

Biopharmaceutical 3PL Market Set to Grow USD 276.24 Bn as Advanced Therapies and Vaccines Drive Global Demand

Hong Kong stocks slip as China’s quarterly growth slows and US tariff threat adds pressure

JPM26, Day 3: AbbVie touts 'clear line of sight' to continued growth into 2030s

0.4444444477558136

Associate Scientist, Upstream Cell Culture

WuXi Biologics is a leading company in the biopharmaceutical industry, and they are seeking an Associate Scientist to analyze, design, and implement upstream cell culture development. The role involves conducting tech transfer and optimization studies using various programs and tools.

President & CEO

Microfluidic Devices Market Size to Reach USD 17.09 Billion by 2033, Driven by Rapid Diagnostics and Lab-on-a-Chip Adoption – SNS Insider

JPM: VieCure raises $43M for cancer care platform

VieCure Raises $43M to Advance AI-Powered Cancer Care

Danaher sees Q4 revenue growth in mid-single digit percent range y/y

Associate Scientist R&D (Cell Culture)

Danaher Corporation, through its operating company Cytiva, is dedicated to transforming human health through innovative solutions. The Associate Scientist R&D will contribute to the development of new products and materials for cell culture bioprocessing, working collaboratively across functions to ensure successful project outcomes.

Chairman and Chief Executive Officer

Chief Financial Officer

Global Molecular Cytogenetics Market Set to Reach USD 1.43 Billion by 2030 | MarketsandMarkets™

Nanotechnology Drug Delivery Market Projected to Reach USD 200.77 Billion by 2032, Owing to Prevalence of Chronic Diseases & Advances in Nanomedicine – SNS Insider

Opinion: How the FDA Is Accelerating Cell and Gene Therapy’s Next Chapter

Hematologic Malignancy Therapeutics Market to Hit US$ 154.32 Billion by 2033 at 8.0% CAGR | DataM Intelligence

Research Associate/Scientist, In Vitro/Cell Culture

Poseida Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on advancing allogeneic cell therapies and genetic medicines. The Research Associate/Scientist role involves primary responsibilities for tissue culture initiation, maintenance, expansion, and cryopreservation of mammalian cells to support in vivo studies in oncology and rare disease gene therapy.